Cargando…

Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer

The advent of targeted therapy has transformed the treatment paradigm and survival of patients with metastatic non-small cell lung cancer (NSCLC) with driver mutations. The development of acquired resistances during treatment with tyrosine kinase inhibitors (TKIs) impedes a prolonged survival in man...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chicas-Sett, Rodolfo, Castilla Martinez, Juan, Hernández Blanquisett, Abrahan, Zafra, Juan, Pastor-Peidro, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884815/ https://www.ncbi.nlm.nih.gov/pubmed/36727053 http://dx.doi.org/10.3389/fonc.2022.1092875

Ejemplares similares

Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients
por: Morales-Orue, Ignacio, et al.
Publicado: (2020)

Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2019)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020)

Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer
por: Wang, Bin, et al.
Publicado: (2022)

Stereotactic Ablative Radiotherapy Fractionation for Hepatocellular Carcinoma in the United States
por: Sheth, Niki, et al.
Publicado: (2020)

Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2017)

Commissioning and initial stereotactic ablative radiotherapy experience with Vero
por: Solberg, Timothy D., et al.
Publicado: (2014)

Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?
por: Fernández, Castalia, et al.
Publicado: (2022)

New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

Predictive Value of Delta-Radiomics Texture Features in 0.35 Tesla Magnetic Resonance Setup Images Acquired During Stereotactic Ablative Radiotherapy of Pancreatic Cancer
por: Simpson, Garrett, et al.
Publicado: (2022)

A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?
por: Al-Shafa, Faiez, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
por: Pan, Yang-Xun, et al.
Publicado: (2020)

Combined Immune Checkpoint Blockade and Stereotactic Ablative Radiotherapy Can Stimulate Response to Immunotherapy in Metastatic Melanoma: A Case Report
por: Moran, Angel, et al.
Publicado: (2019)

Treatment of Residual, Recurrent, or Metastatic Intracranial Hemangiopericytomas With Stereotactic Radiotherapy Using CyberKnife
por: Huang, Lichao, et al.
Publicado: (2021)

Abscopal effect in metastatic breast cancer treated with stereotactic body radiotherapy in the absence of immunotherapy
por: Kim, Jae Sik, et al.
Publicado: (2023)

Intravascular Biphasic Synovial Sarcoma: The Beneficial Role of Adjuvant Treatment Approach in the Pre-metastatic Stage
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2016)

Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations
por: Regnery, Sebastian, et al.
Publicado: (2022)

Commentary: Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
por: Li, Zhaonan, et al.
Publicado: (2021)

Health-related quality of life of salvage prostate reirradiation using stereotactic ablative radiotherapy with urethral-sparing
por: Greco, Carlo, et al.
Publicado: (2022)

Training and Validation of Deep Learning-Based Auto-Segmentation Models for Lung Stereotactic Ablative Radiotherapy Using Retrospective Radiotherapy Planning Contours
por: Wong, Jordan, et al.
Publicado: (2021)

Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Katano, Atsuto, et al.
Publicado: (2023)

Immunoradiotherapy as an Effective Therapeutic Strategy in Lung Cancer: From Palliative Care to Curative Intent
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2020)

Quantification of interplay and gradient effects for lung stereotactic ablative radiotherapy (SABR) treatments
por: Tyler, Madelaine K.
Publicado: (2016)

Migration of implanted markers for image‐guided lung tumor stereotactic ablative radiotherapy
por: Hong, Julian C., et al.
Publicado: (2013)

Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians
por: Schullian, Peter, et al.
Publicado: (2019)

Outcomes of Stereotactic Body Radiotherapy for Metastatic Colorectal Cancer With Oligometastases, Oligoprogression, or Local Control of Dominant Tumors
por: Ji, Xiaoqin, et al.
Publicado: (2021)

BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients
por: Ippolito, Edy, et al.
Publicado: (2023)

A Case of Metastatic Head and Neck Squamous Cell Carcinoma with Multiple Treatments Including Stereotactic Ablative Body Radiotherapy Alone for Oligometastases to the Parotid Gland
por: Sharrett, Jonathan, et al.
Publicado: (2015)

Plan quality analysis of stereotactic ablative body radiotherapy treatment planning in liver tumor
por: Watcharawipha, Anirut, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study
por: Hiniker, Susan M., et al.
Publicado: (2019)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer
por: Chen, Lily, et al.
Publicado: (2022)

Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
por: Brunner, Thomas B., et al.
Publicado: (2021)

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases
por: Shen, Yuxin, et al.
Publicado: (2021)

Definitive Treatment of Early-Stage Non-Small Cell Lung Cancer with Stereotactic Ablative Body Radiotherapy in a Community Cancer Center Setting
por: Heal, Cory, et al.
Publicado: (2015)

A Retrospective Review of CyberKnife Stereotactic Body Radiotherapy for Adrenal Tumors (Primary and Metastatic): Winthrop University Hospital Experience
por: Desai, Amishi, et al.
Publicado: (2015)

The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
por: Finkelstein, Steven Eric, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tgv1oren6tb0a5jbk3t2110q44